Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radek Spisek

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Trends in Cancer|February 19, 2022
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agentsJitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, et al.
International Journal of Cancer|February 7, 2014
High hydrostatic pressure induces immunogenic cell death in human tumor cellsJitka Fucikova, Irena Moserova, Iva Truxova, et al.
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Frontiers in Immunology|October 27, 2022
SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activityZuzana Antosova, Nada Podzimkova, Jakub Tomala, et al.
Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.
European Journal of Human Genetics : EJHG|November 24, 2011
Case report: type 1 diabetes in monozygotic quadrupletsKaterina Stechova, Zbynek Halbhuber, Miluse Hubackova, et al.
Oncoimmunology|July 3, 2015
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyJonathan Pol, Erika Vacchelli, Fernando Aranda, et al.
Oncoimmunology|July 9, 2015
Trial watch: Naked and vectored DNA-based anticancer vaccinesNorma Bloy, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 10, 2015
Trial Watch: Adoptive cell transfer for oncological indicationsFernando Aranda, Aitziber Buqué, Norma Bloy, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
Trends in Cancer|February 19, 2022
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agentsJitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, et al.
International Journal of Cancer|February 7, 2014
High hydrostatic pressure induces immunogenic cell death in human tumor cellsJitka Fucikova, Irena Moserova, Iva Truxova, et al.
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Frontiers in Immunology|October 27, 2022
SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activityZuzana Antosova, Nada Podzimkova, Jakub Tomala, et al.
Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.
European Journal of Human Genetics : EJHG|November 24, 2011
Case report: type 1 diabetes in monozygotic quadrupletsKaterina Stechova, Zbynek Halbhuber, Miluse Hubackova, et al.
Oncoimmunology|July 3, 2015
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyJonathan Pol, Erika Vacchelli, Fernando Aranda, et al.
Oncoimmunology|July 9, 2015
Trial watch: Naked and vectored DNA-based anticancer vaccinesNorma Bloy, Aitziber Buqué, Fernando Aranda, et al.
Oncoimmunology|October 10, 2015
Trial Watch: Adoptive cell transfer for oncological indicationsFernando Aranda, Aitziber Buqué, Norma Bloy, et al.
Pageof 9